Interventional Oncology Devices – Market Insights – Latin America (Supplemental)

Despite the short-term challenges posed by the COVID-19 pandemic, the Latin America interventional oncology device market will see moderate growth through 2031 driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of new competitors. However, a lack of reimbursement and pricing pressures will remain a challenge.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in the Latin America region from 2019 through 2031.

Table of contents

Interventional Oncology Devices - Market Insights - Latin America (Supplemental)

Dhananjay S Raja

Dhananjay Raja is an associate healthcare research and data analyst in the Cardiovascular Medtech Insights team at Clarivate, specializing in the interventional oncology and electrophysiology mapping and ablation device markets. Dhananjay holds a Bachelor’s degree in Chemistry from Shiv Nadar University and is currently pursuing a second Bachelor’s degree in Data Science and Programming at the Indian Institute of Technology, Madras.

Contact sales Login to access report

Back to all Medtech Insights reports